Wire Stories

SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical…

Worldwide Rubber Additives Industry to 2027 – Featuring Arkema, BASF and Lanxess Among Others – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Rubber Additives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027"…

Kubota Vision Announced End of Phase 3 Clinical Trial of Emixustat in Patients with Stargardt Disease

SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota…

Enteral Nutrition Market Research Report 2022: Growing at a CAGR of 9.62% to $8.6+ Billion by 2027 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Enteral Nutrition Market Research Report by Product (Nutrition for Chronic Illness and Standard…

Japan Travel Insurance Market 2022-2027 With Ansoff Analysis – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Japan Travel Insurance Market (2022-2027) by Type, Distribution, End-User, Competitive Analysis and the…

Hytera Honored with International Critical Communications Awards at CCW 2022

VIENNA--(BUSINESS WIRE)--#CommunicationSolutions--Hytera is proud to announce that its Hytera HyTalk MC Solution for Sri Lanka…

Global E-Pharmacy Market Size & Share to 2027 – Featuring Pharmacy2U, Gordons Direct and MedPlus Health Services Among Others – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global E-Pharmacy Market Size & Share to 2027" report has been added to…

AM Best Affirms Credit Ratings of Dhipaya Insurance Public Company Limited

SINGAPORE--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term…

Hytera at CCW 2022 Is Showcasing Convergence-Native Solutions for Critical Communications Sector

VIENNA--(BUSINESS WIRE)--#5G--Critical Communications Week (CCW) took place in Vienna, Austria on 21st June, 2022. The…

Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA® ?(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)

CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who…